Baystate Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $3.51K | Buy |
+4
| New | +$3.51K | ﹤0.01% | 957 |
|
|
2023
Q3 | – | Sell |
-8
| Closed | -$5.75K | – | 1095 |
|
|
2023
Q2 | $5.75K | Hold |
8
| – | – | ﹤0.01% | 678 |
|
|
2023
Q1 | $6.57K | Buy |
8
+6
| +300% | +$4.93K | ﹤0.01% | 638 |
|
|
2022
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 894 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 998 |
|
|
2022
Q2 | – | Sell |
-7
| Closed | -$5K | – | 1010 |
|
|
2022
Q1 | $5K | Hold |
7
| – | – | ﹤0.01% | 656 |
|
|
2021
Q4 | $4K | Hold |
7
| – | – | ﹤0.01% | 689 |
|
|
2021
Q3 | $4K | Hold |
7
| – | – | ﹤0.01% | 620 |
|
|
2021
Q2 | $4K | Hold |
7
| – | – | ﹤0.01% | 589 |
|
|
2021
Q1 | $3K | Hold |
7
| – | – | ﹤0.01% | 568 |
|
|
2020
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 542 |
|
|
2020
Q3 | $4K | Hold |
7
| – | – | ﹤0.01% | 477 |
|
|
2020
Q2 | $4K | Hold |
7
| – | – | ﹤0.01% | 489 |
|
|
2020
Q1 | $3K | Hold |
7
| – | – | ﹤0.01% | 479 |
|
|
2019
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 492 |
|
|
2019
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 488 |
|
|
2019
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 501 |
|
|
2019
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 518 |
|
|
2018
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 484 |
|
|
2018
Q3 | $3K | Hold |
7
| – | – | ﹤0.01% | 491 |
|
|
2018
Q2 | $3K | Hold |
7
| – | – | ﹤0.01% | 510 |
|
|
2018
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 517 |
|
|
2017
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 514 |
|
|
2017
Q3 | $3K | Hold |
7
| – | – | ﹤0.01% | 462 |
|
|
2017
Q2 | $3K | Sell |
7
-80
| -92% | -$34.3K | ﹤0.01% | 462 |
|
|
2017
Q1 | $32K | Hold |
87
| – | – | 0.01% | 217 |
|
|
2016
Q4 | $33K | Buy |
+87
| New | +$33K | 0.01% | 180 |
|